ProteKt Therapeutics

ProteKt Therapeutics Develops Potent and Selective Inhibitors of Kinase PKR for the Treatment of Neurodegenerative and Neuroinflammatory Diseases. ProteKt Therapeutics Discovers and Develops a Series of Novel Selective Molecules by Applying Unique Computational Methods and Validating Inhibitors in Clinically Relevant Assays. ProteKt Utilizes Advanced Computational and Biochemical Methods to Identify Novel, Effective, and Selective Proprietary Small Molecule Inhibitors of PKR.